Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,795 | 695 | 46.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $14,475 | 19 | 45.7% |
| Consulting Fee | $990.00 | 1 | 3.1% |
| Travel and Lodging | $933.52 | 30 | 2.9% |
| Education | $491.92 | 8 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Incyte Corporation | $18,628 | 148 | $0 (2024) |
| Dermavant Sciences, Inc. | $2,327 | 45 | $0 (2024) |
| ABBVIE INC. | $1,860 | 100 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,069 | 54 | $0 (2024) |
| Janssen Biotech, Inc. | $1,062 | 40 | $0 (2024) |
| LEO Pharma Inc. | $944.73 | 83 | $0 (2024) |
| PFIZER INC. | $912.63 | 41 | $0 (2024) |
| Amgen Inc. | $808.04 | 43 | $0 (2024) |
| GENZYME CORPORATION | $572.25 | 23 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $555.82 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,086 | 233 | Incyte Corporation ($6,917) |
| 2023 | $10,928 | 213 | Incyte Corporation ($7,704) |
| 2022 | $6,466 | 171 | Incyte Corporation ($3,964) |
| 2021 | $2,205 | 136 | LEO Pharma Inc. ($313.37) |
All Payment Transactions
753 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | CIBINQO (Drug), LITFULO | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Inflammation & Immunology | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Incyte Corporation | OPZELURA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Dermatology | ||||||
| 12/09/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Dermatology | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $34.35 | General |
| Category: Immunology | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $0.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $29.29 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: Dermatology | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $17.91 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.75 | General |
| Category: Immunology | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.66 | General |
| Category: DERMATOLOGY | ||||||
| 11/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Incyte Corporation | OPZELURA (Drug) | Travel and Lodging | Cash or cash equivalent | $30.82 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.40 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 298 | 438 | $95,535 | $22,181 |
| 2022 | 8 | 236 | 413 | $75,740 | $19,907 |
| 2021 | 8 | 215 | 256 | $66,360 | $16,115 |
| 2020 | 4 | 92 | 110 | $26,745 | $6,524 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 118 | $23,010 | $7,689 | 33.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 56 | 60 | $21,000 | $4,323 | 20.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 20 | 30 | $15,000 | $2,691 | 17.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 33 | 33 | $8,250 | $2,502 | 30.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 42 | 52 | $7,800 | $1,955 | 25.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 22 | 30 | $9,000 | $1,250 | 13.9% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 22 | 22 | $4,950 | $876.35 | 17.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 14 | 15 | $2,625 | $577.95 | 22.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 11 | 78 | $3,900 | $317.32 | 8.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 112 | $21,840 | $7,544 | 34.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 39 | 48 | $16,800 | $3,790 | 22.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 26 | 26 | $6,500 | $2,317 | 35.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 42 | 50 | $7,500 | $2,233 | 29.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 21 | 35 | $10,500 | $1,717 | 16.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 14 | 23 | $4,025 | $993.39 | 24.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 15 | 15 | $3,375 | $740.35 | 21.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 13 | 104 | $5,200 | $571.34 | 11.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 76 | $15,135 | $4,921 | 32.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 35 | 38 | $13,300 | $2,881 | 21.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 28 | 28 | $7,000 | $2,198 | 31.4% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 15 | 25 | $12,500 | $2,182 | 17.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 32 | 35 | $5,350 | $1,476 | 27.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 16 | 21 | $6,300 | $993.44 | 15.8% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 20 | 20 | $4,500 | $881.60 | 19.6% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 12 | 13 | $2,275 | $582.15 | 25.6% |
About Christopher Palines, PA-C
Christopher Palines, PA-C is a Physician Assistant healthcare provider based in Yonkers, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1851542583.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Palines, PA-C has received a total of $31,686 in payments from pharmaceutical and medical device companies, with $12,086 received in 2024. These payments were reported across 753 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($14,795).
As a Medicare-enrolled provider, Palines has provided services to 841 Medicare beneficiaries, totaling 1,217 services with total Medicare billing of $64,727. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Yonkers, NY
- Active Since 09/30/2008
- Last Updated 06/19/2020
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1851542583
Products in Payments
- OPZELURA (Drug) $18,346
- VTAMA (Drug) $2,327
- RINVOQ (Biological) $1,142
- DUPIXENT (Biological) $1,128
- Sotyktu (Drug) $1,043
- EUCRISA (Drug) $861.94
- TREMFYA (Drug) $844.72
- ADBRY (Biological) $614.97
- Otezla (Drug) $612.90
- SKYRIZI (Biological) $545.09
- ENSTILAR (Drug) $329.76
- Winlevi (Drug) $326.01
- Bimzelx (Biological) $234.14
- COSENTYX (Biological) $228.59
- Zoryve (Drug) $223.73
- REMICADE (Biological) $217.76
- TALTZ (Drug) $214.19
- QBREXZA (Drug) $190.22
- ZILXI (Drug) $143.58
- Cimzia (Drug) $120.77
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Yonkers
Mrs. Christianne Eppinette, Pa, PA
Physician Assistant — Payments: $2,832
Avraam Pipko, Pa, PA
Physician Assistant — Payments: $2,534
Maria Villamia
Physician Assistant — Payments: $1,213
Cora Piselli, Pa, PA
Physician Assistant — Payments: $932.24
Yana Michaels
Physician Assistant — Payments: $604.19
Dominique Zadrima, Pa-C, PA-C
Physician Assistant — Payments: $377.77